1. Home
  2. UNCY vs CMBM Comparison

UNCY vs CMBM Comparison

Compare UNCY & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • CMBM
  • Stock Information
  • Founded
  • UNCY 2016
  • CMBM 2011
  • Country
  • UNCY United States
  • CMBM United States
  • Employees
  • UNCY N/A
  • CMBM N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • UNCY Health Care
  • CMBM Technology
  • Exchange
  • UNCY Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • UNCY 31.9M
  • CMBM 26.5M
  • IPO Year
  • UNCY 2021
  • CMBM 2019
  • Fundamental
  • Price
  • UNCY $0.66
  • CMBM $0.70
  • Analyst Decision
  • UNCY Strong Buy
  • CMBM Strong Buy
  • Analyst Count
  • UNCY 4
  • CMBM 3
  • Target Price
  • UNCY $5.50
  • CMBM $5.50
  • AVG Volume (30 Days)
  • UNCY 1.5M
  • CMBM 144.6K
  • Earning Date
  • UNCY 11-13-2024
  • CMBM 11-07-2024
  • Dividend Yield
  • UNCY N/A
  • CMBM N/A
  • EPS Growth
  • UNCY N/A
  • CMBM N/A
  • EPS
  • UNCY N/A
  • CMBM N/A
  • Revenue
  • UNCY N/A
  • CMBM $172,215,000.00
  • Revenue This Year
  • UNCY N/A
  • CMBM N/A
  • Revenue Next Year
  • UNCY N/A
  • CMBM $16.49
  • P/E Ratio
  • UNCY N/A
  • CMBM N/A
  • Revenue Growth
  • UNCY N/A
  • CMBM N/A
  • 52 Week Low
  • UNCY $0.20
  • CMBM $0.66
  • 52 Week High
  • UNCY $1.82
  • CMBM $6.50
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 52.04
  • CMBM 26.27
  • Support Level
  • UNCY $0.62
  • CMBM $0.66
  • Resistance Level
  • UNCY $0.87
  • CMBM $1.25
  • Average True Range (ATR)
  • UNCY 0.08
  • CMBM 0.11
  • MACD
  • UNCY -0.01
  • CMBM -0.04
  • Stochastic Oscillator
  • UNCY 15.45
  • CMBM 6.79

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: